FAS has upgraded our forum security. Some members may need to log in again. If you are unable to remember your login information, please email food.allergy.supt@flash.net and we will help you get back in. Thanks for your patience!

Author Topic: Apr 30, 2010: Children's Medications recalled ***  (Read 1399 times)

Description: Tylenol, Motrin, Benedryl, Zyrtec

Offline GingerPye

  • Moderator
  • Member
  • ****
  • Posts: 15,460
Apr 30, 2010: Children's Medications recalled ***
« on: September 14, 2011, 09:28:30 AM »
http://allergy.hyperboards.com/action/view_topic/topic_id/15222

http://www.theglobeandmail.com/news/technology/science/childrens-tylenol-motrin-recalled-in-canada-over-quality-questions/article1553495/

More than 40 over-the-counter infant's and children's liquid medications are being recalled in the United States, Canada and 10 other countries because they don't meet quality standards.

McNeil Consumer Healthcare issued the recall in the USA for children's versions of Tylenol, Tylenol Plus, Motrin, Zyrtec and Benadryl after consulting with the Food and Drug Administration.

In Canada, it said Saturday the impact is limited to all lots of children's Motrin and infants' Motrin liquid suspension products and children's Tylenol cough and runny nose liquid suspension only.

The company is recalling the products because some did not meet required quality standards, it said in a statement Friday.

Some of the products recalled may have a higher concentration of active ingredient than is specified on the bottle. Others may contain particles, while still others may contain inactive ingredients that do not meet internal testing requirements.
 
 ********
Here's the list:

http://www.mcneilproductrecall.com/page.jhtml?id=/include/new_recall.inc

********

And here's more...

McNeil Consumer Healthcare Announces Voluntary Recall of Certain OTC Infants’ and Children’s Products



FOR IMMEDIATE RELEASE - April 30, 2010 – Fort Washington, PA. McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., in consultation with the U.S. Food and Drug Administration (FDA), is voluntarily recalling all lots that have not yet expired of certain over-the-counter (OTC) Children’s and Infants’ liquid products manufactured in the United States and distributed in the United States, Canada, Dominican Republic, Dubai (UAE), Fiji, Guam, Guatemala, Jamaica, Puerto Rico, Panama, Trinidad & Tobago, and Kuwait. (SEE RECALLED PRODUCT LIST BELOW).

McNeil Consumer Healthcare is initiating this voluntary recall because some of these products may not meet required quality standards. This recall is not being undertaken on the basis of adverse medical events. However, as a precautionary measure, parents and caregivers should not administer these products to their children. Some of the products included in the recall may contain a higher concentration of active ingredient than is specified; others may contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny particles. While the potential for serious medical events is remote, the company advises consumers who have purchased these recalled products to discontinue use.

The company is conducting a comprehensive quality assessment across its manufacturing operations and has identified corrective actions that will be implemented before new manufacturing is initiated at the plant where the recalled products were made.
Consumers can contact the company at 1-888-222-6036 and also at http://www.mcneilproductrecall.com. Parents and caregivers who are not sure about alternative pediatric health treatment options should talk to their doctor or pharmacist and are reminded to never give drug products to infants and children that are not intended for those age groups as this could result in serious harm

For additional information, including affected NDC numbers, consumers should visit our website http://www.mcneilproductrecall.com or call 1-888-222-6036 (Monday-Friday 8 a.m. to 10 p.m. Eastern Time, and Saturday-Sunday 9 a.m. to 5 p.m. Eastern Time). Any adverse reactions may also be reported to the FDA’s MedWatch Program by fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at http://www.fda.gov/medwatch1.|

McNeil Consumer Healthcare, Division of McNeil-PPC, Inc. markets a broad range of well-known OTC products. 
  Logged 
 
  ***  multiple posts not included here on old FAS; please see link at beginning ***
DD, 25 - MA/EA/PA/env./eczema/asthma
DS, 22 - MA/EA/PA/env.
DH - adult-onset asthma
me - env. allergies, exhaustion, & mental collapse ...